MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biostem Technologies New (OP:BSEM)

4.320 -0.714 (-14.18%)
Streaming Delayed Price Updated: 3:53 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 135,336
Open 4.530
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 5.034
Today's Range 4.000 - 4.530
52wk Range 3.093 - 14.52
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioStem Technologies Q1 Earnings Call Highlights ↗
BioStem Technologies (OTCMKTS:BSEM) said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company’s focus from physician offices... 
Via MarketBeat
Topics Earnings
News headline image
Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
Via AB Newswire

Performance

YTD
+10.5%
+10.5%
1 Month
-7.7%
-7.7%
3 Month
-25.5%
-25.5%
6 Month
+8.7%
+8.7%
1 Year
-64.0%
-64.0%

More News

Read More
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
Via AB Newswire
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
Via AB Newswire
Topics Intellectual Property
News headline image
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
Via ACCESSWIRE
News headline image
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
Via ACCESSWIRE
News headline image
BioStem Technologies: CMS Decision a “Win For Patients”
Via ACCESSWIRE
News headline image
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
Via ACCESSWIRE
News headline image
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
Via ACCESSWIRE
News headline image
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
Via ACCESSWIRE
News headline image
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond ↗
Via Benzinga
News headline image
2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion ↗
Via Benzinga
News headline image
BioStem Technologies Announces Partnership with Kill Cliff FC
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
From BioStem Technologies, Inc.
Via GlobeNewswire
News headline image
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research ↗
Via Benzinga
News headline image
EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY ↗
Via Benzinga
Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness ↗
Via Benzinga
Topics Cannabis

Frequently Asked Questions

Is Biostem Technologies New publicly traded?
Yes, Biostem Technologies New is publicly traded.
What exchange does Biostem Technologies New trade on?
Biostem Technologies New trades on the OTC Traded
What is the ticker symbol for Biostem Technologies New?
The ticker symbol for Biostem Technologies New is BSEM on the OTC Traded
What is the current price of Biostem Technologies New?
The current price of Biostem Technologies New is 4.320
When was Biostem Technologies New last traded?
The last trade of Biostem Technologies New was at 05/15/26 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story